A differential pulse voltammetry (DPV) method has been applied for the first time for determination of trans-Pt[Cl2(OH)2(dimethylamine)(isopropylamine)]. To this end, all chemical and instrumental variables affecting the determination of trans-Pt[Cl2(OH)2(dimethylamine)(isopropylamine)] were optimized. From studies of the mechanisms governing the electrochemical response of trans-Pt[Cl2(OH)2(dimethylamine)(isopropylamine)], it was concluded that it is an electrochemically irreversible system with a reduction under diffusion control, with a reduction potential of -425 mV. Under optimal conditions, the variation in the analytical signal (Ip) with trans-Pt[Cl2(OH)2(dimethylamine)(isopropylamine)] concentration is linear in the 0.8 µg mL-1 to ...
The use of Pt-containing compounds as chemotherapeutic agents facilitates drug monitoring by using ...
Reported here is a study of the solution chemistry of the anti-cancer drug cis-dichloro-diammineplat...
Treatment strategies for tumour diseases are progressively focusing on personalization of medicine. ...
A differential pulse voltammetry (DPV) method has been applied for the first time for determination ...
The analysis of cisplatin has been investigated using a variety of electrochemical and chromatograp...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
International audienceCisplatin (cis-diamminedichloroplatinum(II) is the first platinum-based antitu...
Cancerous diseases remain a major threat to human population causing millions of deaths every year. ...
Because Platinum Group Elements have found widespread use in catalytic converters in cars and as che...
We report the design and fabrication of a reagentless and reusable electrochemical sensor for detect...
A novel trans-platinum(II) complex bearing one dimethylamine (dma) and one methylamine (ma) ligand, ...
Platinum-based (Pt) electrodes are used ubiquitously in neurostimulation for their high charge capac...
Platinum complexes, bearing aliphatic amines and phosphine ligands in trans configuration with iodid...
Patients cured of metastatic testicular cancer with cisplatin chemotherapy may suffer late adverse e...
This article reviews approaches on platinum speciation with respect to Pt drugs in anti-cancer thera...
The use of Pt-containing compounds as chemotherapeutic agents facilitates drug monitoring by using ...
Reported here is a study of the solution chemistry of the anti-cancer drug cis-dichloro-diammineplat...
Treatment strategies for tumour diseases are progressively focusing on personalization of medicine. ...
A differential pulse voltammetry (DPV) method has been applied for the first time for determination ...
The analysis of cisplatin has been investigated using a variety of electrochemical and chromatograp...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
International audienceCisplatin (cis-diamminedichloroplatinum(II) is the first platinum-based antitu...
Cancerous diseases remain a major threat to human population causing millions of deaths every year. ...
Because Platinum Group Elements have found widespread use in catalytic converters in cars and as che...
We report the design and fabrication of a reagentless and reusable electrochemical sensor for detect...
A novel trans-platinum(II) complex bearing one dimethylamine (dma) and one methylamine (ma) ligand, ...
Platinum-based (Pt) electrodes are used ubiquitously in neurostimulation for their high charge capac...
Platinum complexes, bearing aliphatic amines and phosphine ligands in trans configuration with iodid...
Patients cured of metastatic testicular cancer with cisplatin chemotherapy may suffer late adverse e...
This article reviews approaches on platinum speciation with respect to Pt drugs in anti-cancer thera...
The use of Pt-containing compounds as chemotherapeutic agents facilitates drug monitoring by using ...
Reported here is a study of the solution chemistry of the anti-cancer drug cis-dichloro-diammineplat...
Treatment strategies for tumour diseases are progressively focusing on personalization of medicine. ...